As America battles an epidemic of deaths from misused pain pills, a new study suggests an inexpensive way to cut risky use of these drugs by people who have a high chance of overdosing. And it could happen exactly where many patients get those drugs in the first place: the emergency room of their local hospital.
About a quarter of women experience moderate to severe pain for many years after breast cancer treatment ends. In many cases, it’s a type of pain that is challenging to treat, with few or no effective options. A U-M researcher is trying to understand who is most likely to experience pain related to breast cancer and how best to treat it.
Across the country, patients use marijuana in hopes that it will ease the symptoms of many conditions. But there isn't much research on medical marijuana. Now, U-M researchers have received funding to study the issue.
The antidepressant drug duloxetine, known commercially as Cymbalta, helped relieve painful numbness and tingling feelings caused by chemotherapy in 59 percent of patients, a new study finds. This is the first clinical trial to find an effective treatment for this pain.
The Michigan Neurosport Concussion Program is now offering free, online courses for youth and high school coaches with up-to-date information about recognizing concussions and the best practices for responding.
In the first clinical trial of gene therapy for treatment of intractable pain, researchers from the University of Michigan Department of Neurology observed that the treatment appears to provide substantial pain relief.
More than 40 percent of cancer survivors have experienced cancer pain since their diagnosis and many have current cancer-related chronic pain, according to research by the University of Michigan Health System. The study, funded by the Lance Armstrong Foundation, provides new insight on issues facing the growing number of U.S. cancer survivors. The results were published in the American Cancer Society's journal Cancer.